Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-18

FDA Approved: PROSTIN VR PEDIATRIC — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental application for PROSTIN VR PEDIATRIC (alprostadil) submitted by Pharmacia & Upjohn Company LLC. The action pertains to a pediatr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROSTIN VR PEDIATRIC (ALPROSTADIL)

Snippet

SUPPL AP for PROSTIN VR PEDIATRIC (ALPROSTADIL)